Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
Filed Apr 30, 2019 · 10-Q · 30 days after period end · 0001091818-19-000131
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Revenue | $5.85K | — |
| Net Income | -$12.85K | -$23.97K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed Apr 30, 2019 · 30 d after period end